Screener

R&D

Name: LivaNova R&D by Business Segments
Creator: OpenCapital
License: https://www.opencapital.sh/terms

LivaNova·Business Segments·2 segments·Rolls up to R&D

Breakdown

Segment	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26	Q2 '26
Neuromodulation	$25.58M	$29.78M	$30.71M	$32.85M	$40.79M	$34.99M
Cardiopulmonary	$12.04M	$16.47M	$18.11M	$19.12M	$17.8M	$18.38M
Total	$37.88M	$47.19M	$48.58M	$52.12M	$58.7M	$53.66M

CardiopulmonaryView metric

NeuromodulationView metric